HTML from...
URL: https://open.canada.ca/data/en/dataset/78ec33b7-b968-453f-86a7-11f17c17cf97
Health Canada carried out this safety review when it became aware that the FDA was investigating the risk of angle-closure glaucoma linked to antidepressant use. Angle-closure glaucoma is a serious eye disorder where eye fluid drainage is blocked, leading to a sudden increase in the pressure in the eye and causing pain and blurred vision. If not treated immediately, angle-closure glaucoma can lead to permanent vision loss.
There are no views created for this resource yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | January 16, 2026 |
| Metadata last updated | January 16, 2026 |
| Created | January 16, 2026 |
| Format | HTML |
| License | License not specified |
| Datastore active | False |
| Has views | False |
| Id | 2c49008f-aaf9-43ee-aa8a-8d081586d9ec |
| Package id | f7cf31e7-e571-47f9-a345-c8475eac0c7e |
| Position | 0 |
| State | active |